ZA911720B - Sustained release pharmaceutical composition - Google Patents
Sustained release pharmaceutical compositionInfo
- Publication number
- ZA911720B ZA911720B ZA911720A ZA911720A ZA911720B ZA 911720 B ZA911720 B ZA 911720B ZA 911720 A ZA911720 A ZA 911720A ZA 911720 A ZA911720 A ZA 911720A ZA 911720 B ZA911720 B ZA 911720B
- Authority
- ZA
- South Africa
- Prior art keywords
- sustained release
- pharmaceutical composition
- release pharmaceutical
- drug
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909005498A GB9005498D0 (en) | 1990-03-12 | 1990-03-12 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA911720B true ZA911720B (en) | 1992-02-26 |
Family
ID=10672453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA911720A ZA911720B (en) | 1990-03-12 | 1991-03-08 | Sustained release pharmaceutical composition |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0519950B1 (de) |
| JP (1) | JPH05504574A (de) |
| AT (1) | ATE117893T1 (de) |
| AU (1) | AU643263B2 (de) |
| CA (1) | CA2077994A1 (de) |
| DE (1) | DE69107202T2 (de) |
| DK (1) | DK0519950T3 (de) |
| ES (1) | ES2069880T3 (de) |
| GB (1) | GB9005498D0 (de) |
| GR (1) | GR3015821T3 (de) |
| HK (1) | HK1004529A1 (de) |
| IE (1) | IE65123B1 (de) |
| WO (1) | WO1991013612A1 (de) |
| ZA (1) | ZA911720B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9402029D0 (en) * | 1994-02-03 | 1994-03-30 | Smithkline Beecham Plc | Novel formulation |
| US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| CA2269679A1 (en) * | 1996-12-20 | 1998-07-02 | Warner-Lambert Company | Antitussive drugs delivered by partially coated ion exchange resins |
| EP1117384A1 (de) | 1998-10-01 | 2001-07-25 | Elan Pharma International Limited | Nanopartikelformulierungen mit kontrollierter wirkstofffreisetzung |
| DE60232290D1 (de) * | 2001-04-09 | 2009-06-25 | Rohm & Haas | Kontrollierte Auflösung von Wirkstoffen |
| US9149440B2 (en) | 2003-09-02 | 2015-10-06 | University Of South Florida | Nanoparticles for drug-delivery |
| US20050238695A1 (en) * | 2004-04-27 | 2005-10-27 | Atma Chaudhari | Lozenge for delivery of dextromethorphan |
| US8313770B2 (en) * | 2007-05-30 | 2012-11-20 | Neos Therapeutics, Lp | Modifying drug release in suspensions of ionic resin systems |
| US20130190299A1 (en) | 2010-06-30 | 2013-07-25 | Victoria Link Ltd. | Methods and compositions for treatment of multiple sclerosis |
| WO2017017699A1 (en) * | 2015-07-27 | 2017-02-02 | Sun Pharma Advanced Research Company Limited | Drug loaded nanoresin particles |
| EP4041309A4 (de) * | 2019-10-10 | 2023-11-01 | Brillian Pharma Inc. | Pharmazeutische zusammensetzung auf der basis von mikronisiertem wirkstoffresinat und verfahren zu ihrer herstellung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990332A (en) * | 1958-04-02 | 1961-06-27 | Wallace & Tiernan Inc | Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith |
| US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
| US4788055A (en) * | 1985-12-09 | 1988-11-29 | Ciba-Geigy Corporation | Resinate sustained release dextromethorphan composition |
| US4894239A (en) * | 1987-06-02 | 1990-01-16 | Takeda Chemical Industries, Ltd. | Sustained-release preparation and production thereof |
| US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
-
1990
- 1990-03-12 GB GB909005498A patent/GB9005498D0/en active Pending
-
1991
- 1991-03-04 AU AU73483/91A patent/AU643263B2/en not_active Ceased
- 1991-03-04 AT AT91905284T patent/ATE117893T1/de not_active IP Right Cessation
- 1991-03-04 WO PCT/GB1991/000324 patent/WO1991013612A1/en active IP Right Grant
- 1991-03-04 JP JP3504996A patent/JPH05504574A/ja active Pending
- 1991-03-04 ES ES91905284T patent/ES2069880T3/es not_active Expired - Lifetime
- 1991-03-04 CA CA002077994A patent/CA2077994A1/en not_active Abandoned
- 1991-03-04 DK DK91905284.5T patent/DK0519950T3/da active
- 1991-03-04 DE DE69107202T patent/DE69107202T2/de not_active Expired - Fee Related
- 1991-03-04 EP EP91905284A patent/EP0519950B1/de not_active Expired - Lifetime
- 1991-03-08 ZA ZA911720A patent/ZA911720B/xx unknown
- 1991-03-11 IE IE79791A patent/IE65123B1/en not_active IP Right Cessation
-
1995
- 1995-04-17 GR GR950400951T patent/GR3015821T3/el unknown
-
1998
- 1998-04-29 HK HK98103673A patent/HK1004529A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2069880T3 (es) | 1995-05-16 |
| DE69107202T2 (de) | 1995-05-24 |
| AU643263B2 (en) | 1993-11-11 |
| HK1004529A1 (en) | 1998-11-27 |
| GR3015821T3 (en) | 1995-07-31 |
| DK0519950T3 (da) | 1995-04-10 |
| CA2077994A1 (en) | 1991-09-13 |
| GB9005498D0 (en) | 1990-05-09 |
| JPH05504574A (ja) | 1993-07-15 |
| DE69107202D1 (de) | 1995-03-16 |
| IE910797A1 (en) | 1991-09-25 |
| IE65123B1 (en) | 1995-10-04 |
| EP0519950A1 (de) | 1992-12-30 |
| ATE117893T1 (de) | 1995-02-15 |
| WO1991013612A1 (en) | 1991-09-19 |
| EP0519950B1 (de) | 1995-02-01 |
| AU7348391A (en) | 1991-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3005477T3 (de) | ||
| HU9601008D0 (en) | Sustained release formulations for 24 hour release of metoprolol | |
| AU4355693A (en) | Ultrafine powder for inhalation and production thereof | |
| HUT76807A (en) | Inhalation composition | |
| EP0951917A3 (de) | Teilchenverabreichung, insbesondere von therapeutischen Mitteln im pulverisierten Zustand | |
| ZA911720B (en) | Sustained release pharmaceutical composition | |
| MY106371A (en) | Oral pharmaceutical compositions in unit dosage form | |
| AU566228B2 (en) | Compressed hydroxybutryic acid polymer retarded release vehicle | |
| MX9803918A (es) | Tabletas de liberacion rapida comprendiendo acido tolfenamico o una sal farmaceuticamente aceptable del mismo como ingrediente activo y un metodo para la preparacion de dicha tableta. | |
| MX9600022A (es) | Excipiente de liberacion sostenida. | |
| GR3031360T3 (en) | Composition based on ibuprofen, for oral usage | |
| CA2176461A1 (en) | Method for preparing low dose pharmaceutical products | |
| IT1252181B (it) | Composizioni farmaceutiche per la somministrazione nasale di polipeptidi. |